MILPITAS, Calif. — Applied StemCell, a CRO/CDMO that blends unique genome editing technology and iPSC expertise, announced the launch of their first hypoimmunogenic hiPSC products which are designed to empower researchers developing next-generation allogeneic cell therapies. The ActiCells™ RUO Hypo hiPSCs (Cat.# ASE-9550) and the ActiCells™ RUO TARGATT™ Hypo hiPSC Knock-in Kit (Cat.# AST-9650) offer powerful tools for building off-the-shelf therapies by combining reduced immunogenicity, robust pluripotency, and genome engineering readiness. They are an isogenic match to the forthcoming GMP-grade versions to offer a seamless path from early research to clinical development. [Read more…]
Pioneering the future of sports with iPS cells
FUNROOTS, I Peace, and Reju form a strategic alliance
FUNROOTS Co., Ltd. (Tokyo, Japan), I Peace, Inc. (California, USA), and Reju Inc. (Tokyo, Japan) entered a strategic partnership to integrate cutting-edge iPS cell technology into the sports industry, aiming to deliver innovative health management solutions, enhance athletic performance, and accelerate injury recovery, leveraging advancements in regenerative medicine. [Read more…]
LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics
LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics
London, 03 April 2025 – LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, and Gift of Life Biologics, (‘GOLB’) a leader in the provision of cellular starting material for cell therapies, announce a collaboration with GOLB as LIfT’s preferred partner for sourcing hematopoietic stem cells (HSCs) for the production of its clinical grade Immunomodulatory Alpha Neutrophils (IMANs), a first-in-class cell therapy designed to overcome treatment resistance in solid tumours as the Company prepares to initiate its clinical trials. [Read more…]
How Amazon, Google, And Apple Are Covertly Tackling The Healthcare Sector
Traditionally known for tech products, Amazon, Google, and Apple are beginning covert ventures into yet another critical sphere of human life, healthcare.
With hundreds of thousands of health-related apps available globally, more than 320 million users engaging with these platforms, and over 600 million wearable devices projected to ship annually by 2026, it is no surprise that companies like Google, Apple, and Amazon are investing heavily in cutting-edge healthcare technologies. [Read more…]
I Peace Launches Personalized iPS Cell Services and Longevity Treatment in the U.S. – Age-Reversed Stem Cell Technology Now Available to the Public –
Palo Alto, CA – I Peace, Inc., a global pioneer in iPSC (induced pluripotent stem cell) technology, proudly announces the launch of its personalized iPS cell production and longevity-focused rejuvenation therapies in the United States.
I Peace CEO Koji Tanabe spoke at the “Unlimited Health Conference,” a part of the Vitalist Bay, the biggest longevity event in the world, which is held in Berkeley, California. The event was held on April 5. [Read more…]
- « Previous Page
- 1
- …
- 37
- 38
- 39
- 40
- 41
- …
- 202
- Next Page »